New Weight-Loss drug HS235 passes early safety check in small study
Symptom relief
Completed
This early-stage study tested a new drug called HS235 in 39 overweight or obese but otherwise healthy adults aged 40 and older. The main goal was to check the drug's safety and how the body processes it, not to prove weight loss. Researchers gave single and multiple doses to see …
Phase: PHASE1 • Sponsor: 35Pharma Inc • Aim: Symptom relief
Last updated Apr 26, 2026 20:02 UTC